OBJECTIVE This open-label, non-randomized, phase I study examined the pharmacokinetics (PK) and radiation dosimetry of a single dose of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastases. METHODS Six male Japanese patients (mean age 72.5 years, range 65-79 years) with histologically or cytologically confirmed stage IV adenocarcinoma of the pro...

Bone metastases, which are commonly seen in patients with advanced cancers, are a major cause of skeletal events, disability, and death. Radium-223 dichloride (radium-223; Xofigo, formerly Alpharadin), a first-in-class, alpha-emitting radiopharmaceutical that selectively targets bone metastases with high-energy short-range alpha-particles, has been approved for the treatment of patients with ca...

Sediment samples were collected from the vicinity of the abandoned South Terras uranium mine in south-west UK and analysed for uranium and (226)Ra to explore their geochemical dispersion. The radioactivity concentrations in the sediment samples were measured using alpha spectrometry for uranium, and gamma spectrometry for radium. Sequential chemical extraction was applied to selected sediments ...

Cesium radioactive isotopes (134Cs and 137Cs) are dangerous to human health due to their long half-life and high solubility in water. Nuclear experiments, wars, and nuclear plant accidents have been the main sources of Cs release into the environment. In recent years, several methods have been introduced for the elimination of Cs radioactive isotopes from contaminated wate...

milligram. As representatives in the British Empire "of the Radium Beige (Union Miniere du Haut Katanga), we would like to have an opportunity of correcting this statement. Previous to the discovery of the rich ores in the Belgian Congo, the standard price for radium element was $110 per milligram, and this price was reduced following the production of radium from the Congo ore to $70, equivale...

In 1936, almost 4 decades after the discovery of the x-ray and of radium, the German Röntgen Society erected a monument to commemorate all who had died as a consequence of exposure to x-rays or radium. George W.C. Kaye of the US National Physical Laboratory wrote the inscription: “To the röntgenologists and radiologists of all nations, doctors, physicists, chemists, technical workers, laborator...

Metastatic castration-resistant prostate cancer (mCRPC) frequently metastasizes to the bone, often resulting in painful skeletal events, reduced quality of life, and reduced survival. The beta-emitting radiopharmaceuticals strontium-89 and samarium-153 alleviated pain in mCRPC patients with widespread skeletal metastases and have been associated with myelotoxicity. Radium-223, a first-in-class ...

INTRODUCTION A number of drugs have been shown to extend life expectancy in castration-resistant prostate cancer (CRPC). Skeletal related events (SREs) secondary to bone metastases cause significant morbidity for men with CRPC. The α-emitting radiopharmaceutical radium-223 dichloride has been shown to improve overall survival, time to symptomatic skeletal events (SSEs) and quality of life in CR...

After practicing medicine for two years, he entered graduate school and in May 2005 received his Ph.D. in Biochemistry and Molecular Genetics at the University of Alabama at Birmingham. He is currently a research associate at the University of Wisconsin-Madison. He is the recipient of the American Medical Association's Physican's Recognition Award and was also recipient of the Outstanding Gradu...

INTRODUCTION Approximately 10 - 20% of prostate cancer cases ultimately progress to castration-resistant prostate cancer (CRPC), for which there is a poor prognosis and a therapeutic need. Radium-223 dichloride (radium-223 [Xofigo]) is a first-in-class α-emitting radiopharmaceutical shown to significantly prolong overall survival in patients with CRPC with symptomatic bone metastases and no vis...